BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| chitosan oligomers {chitooligosaccharides} - Enterococcus malodoratus |
👶
Chitooligosaccharides Prevents the Development of Colitis-Associated Colorectal Cancer by Modulating the Intestinal Microbiota and Mycobiota. Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 2101 Pub: 2019 Epub: 2019 Sep 18 Authors Wu M , Li J , An Y , Li P , Xiong W , Li J , Yan D , Wang M , Zhong G , Html Article Publication |
| chitosan oligomers {chitooligosaccharides} - Enterococcus malodoratus |
👶
Pretreatment with chitosan oligosaccharides attenuate experimental severe acute pancreatitis via inhibiting oxidative stress and modulating intestinal homeostasis. Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: Issue Pages: Pub: 2021 Jan 25 Epub: 2021 Jan 25 Authors Mei QX , Hu JH , Huang ZH , Fan JJ , Huang CL , Lu YY , Wang XP , Zeng Y , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
